Issues for improving multiplasmid DNA vaccines for HIV-1

Author： Muthumani K.   Kudchodkar S.   Zhang D.   Bagarazzi M.L.   Kim J.J.   Boyer J.D.   Ayyavoo V.   Pavlakis G.N.   Weiner D.B.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.15, 2002-05, pp. : 1999-2003

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis

By Bojak A.   Hammer D.   Wolf H.   Wagner R.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1975-1979

Elsevier

Access to resources Recommend Favorite

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice

By Hanke T.   Schneider J.   Gilbert S.C.   Hill A.V.S.   McMichael A.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 426-435

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees

By Bagarazzi M.L.   Boyer J.D.   Ugen K.E.   Javadian M.A.   Chattergoon M.   Shah A.   Bennett M.   Ciccarelli R.   Carrano R.   Coney L.   Weiner D.B.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1836-1841

Elsevier

Access to resources Recommend Favorite

The basis for HIV immunotherapeutic vaccines

By Peters B.S.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 688-705

Elsevier

Access to resources Recommend Favorite

HIV vaccines: the Uganda experience

By Mugyenyi P.N.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1905-1908

Elsevier

Access to resources Recommend Favorite